Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA

8:40 PM ETDeveloping

Health Desk

thyroid cancer (Wikidata P18) — Wikimedia Commons (Public domain). File: Thyroidgland-intl.png

thyroid gland (Wikidata P18) — Photo: CFCF / Wikimedia Commons (CC BY-SA 4.0)

File:Blood seen on Pap smear from thyroid cyst, portrait format.jpg — Photo: Mikael Häggström , M.D. Author info - Reusing images - Conflicts of interest: None Mikael Häggström , M.D. Consent note : Consent from the patient or patient's relatives is

File:Blood seen on Pap smear from thyroid cyst, horizontal format.jpg — Photo: Mikael Häggström , M.D. Author info - Reusing images - Conflicts of interest: None Mikael Häggström , M.D. Consent note : Consent from the patient or patient's relatives is

Vitruvias Therapeutics is recalling one lot of thyroid medication distributed nationwide after testing found the tablets could be more potent than intended, according to a recall notice published by the U.S. Food and Drug Administration (FDA).

DOG FOOD RECALLED ACROSS US AND CANADA AFTER COMPLAINTS OF METAL CONTAMINATION Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, after testing confirmed the product could be more potent than intended. (FDA / Unknown) Elderly patients, pregnant women and infants face greater risks from excessive thyroid hormone levels, particularly with extended use, the company said.

E COLI AND SALMONELLA OUTBREAK LINKED TO ALFALFA SPROUTS SICKENS DOZENS ACROSS MULTIPLE STATES A pharmacist pulls a drug from a shelf inside a pharmacy in Provo, Utah. (George Frey/Bloomberg via , File / ) Patients currently taking tablets from the affected lot should not stop taking the medication without first contacting their healthcare provider for guidance or a replacement prescription, the company said.

Vitruvias Therapeutics said it has not received any reports of adverse events known to be connected to the recall. The company released 3,655 units and reported 1,955 units sold.

What's confirmed

What's still developing

Vitruvias Therapeutics is recalling one lot of thyroid medication distributed nationwide after testing found the tablets could be more potent than intended, according to a recall notice published by the U.S. Food and…
DOG FOOD RECALLED ACROSS US AND CANADA AFTER COMPLAINTS OF METAL CONTAMINATION Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, after testing confirmed the product could be more potent than…
Vitruvias Therapeutics said it has not received any reports of adverse events known to be connected to the recall.
The company released 3,655 units and reported 1,955 units sold.
E COLI AND SALMONELLA OUTBREAK LINKED TO ALFALFA SPROUTS SICKENS DOZENS ACROSS MULTIPLE STATES A pharmacist pulls a drug from a shelf inside a pharmacy in Provo, Utah. (George Frey/Bloomberg via , File / ) Patients…

Sources

Fox Business — source text fetched for this pass link